Idexx Laboratories [IDXX] vs Danaher [DHR] Detailed Stock Comparison

Idexx Laboratories, Inc.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Idexx Laboratories, Inc. wins in 10 metrics, Danaher Corporation wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Idexx Laboratories, Inc. Danaher Corporation Better
P/E Ratio (TTM) 42.92 34.61 Danaher Corporation
Price-to-Book Ratio 27.85 2.40 Danaher Corporation
Debt-to-Equity Ratio 60.83 37.17 Danaher Corporation
PEG Ratio 2.41 3.84 Idexx Laboratories, Inc.
EV/EBITDA 31.12 17.69 Danaher Corporation
Profit Margin (TTM) 24.62% 14.89% Idexx Laboratories, Inc.
Operating Margin (TTM) 29.76% 22.94% Idexx Laboratories, Inc.
EBITDA Margin (TTM) 29.76% 22.94% Idexx Laboratories, Inc.
Return on Equity 66.20% 7.08% Idexx Laboratories, Inc.
Return on Assets (TTM) 25.59% 4.19% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $1.04B $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 7.30% -10.25% Idexx Laboratories, Inc.
Price-to-Sales Ratio (TTM) 10.38 5.10 Danaher Corporation
Enterprise Value $46.85B $140.38B Danaher Corporation
EV/Revenue Ratio 10.89 5.67 Danaher Corporation
Gross Profit Margin (TTM) 60.35% 60.34% Idexx Laboratories, Inc.
Revenue per Share (TTM) $54 $35 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $13.07 $5.16 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.72 0.99 Danaher Corporation
Short % of Float 2.74% 1.10% Danaher Corporation

Idexx Laboratories, Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

IDXX
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: Idexx Laboratories, Inc. vs Danaher Corporation

MetricIDXXDHR
Market Information
Market Cap i$44.66B$126.39B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i480,5025,174,666
90 Day Avg. Volume i516,1144,357,215
Last Close$570.00$181.10
52 Week Range$506.91 - $769.98$160.93 - $242.80
% from 52W High-25.97%-25.41%
All-Time High$769.98 (Nov 26, 2025)$296.06 (Sep 06, 2021)
% from All-Time High-25.97%-38.83%
Growth Metrics
Quarterly Revenue Growth0.14%0.04%
Quarterly Earnings Growth0.15%0.08%
Financial Health
Profit Margin (TTM) i0.25%0.15%
Operating Margin (TTM) i0.30%0.23%
Return on Equity (TTM) i0.66%0.07%
Debt to Equity (MRQ) i60.8337.17
Cash & Liquidity
Book Value per Share (MRQ)$20.14$74.32
Cash per Share (MRQ)$2.26$8.06
Operating Cash Flow (TTM) i$1.18B$6.44B
Levered Free Cash Flow (TTM) i$790.74M$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Idexx Laboratories, Inc. vs Danaher Corporation

MetricIDXX (Apr 24, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i42.9234.61
Forward P/E i34.1919.64
PEG Ratio i2.413.84
Price to Sales (TTM) i10.385.10
Price to Book (MRQ) i27.852.40
Market Capitalization
Market Capitalization i$44.66B$126.39B
Enterprise Value i$46.85B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i10.895.67
Enterprise to EBITDA i31.1217.69
Risk & Other Metrics
Beta i1.720.99
Book Value per Share (MRQ) i$20.14$74.32

Financial Statements Comparison: Idexx Laboratories, Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIDXX (2025)DHR (2025)
Revenue/Sales i4.30B24.57B
Cost of Goods Sold i1.64B10.05B
COGS % of Revenue i38.2%40.9%
Gross Profit i2.66B14.52B
Gross Margin i61.8%59.1%
Research & Development i251.21M1.60B
Operating Income (EBIT) i1.36B4.69B
Operating Margin i31.6%19.1%
EBITDA i1.51B7.17B
EBITDA Margin i35.0%29.2%
Pre-Tax Income i1.32B4.23B
Pre-Tax Income % of Revenue i30.8%17.2%
Income Tax i264.73M633.00M
Income Tax % of Revenue i6.2%2.6%
Net Income (Profit) i1.06B3.61B
Profit Margin i24.6%14.7%

Balance Sheet & Liquidity Metrics

MetricIDXX (2025)DHR (2025)
Cash & Equivalents i180.07M4.62B
Total Current Assets i1.41B12.76B
Total Current Assets % of Revenue i32.9%51.9%
Total Current Liabilities i1.15B6.81B
Total Current Liabilities % of Revenue i26.7%27.7%
Long-Term Debt i475.99M19.50B
Long-Term Debt % of Revenue i11.1%79.4%
Total Shareholders Equity i1.61B52.54B
Retained Earnings i6.39B46.89B
Retained Earnings % of Revenue i148.5%190.9%
Property, Plant & Equipment i123.23M2.14B

Cash Flow Statement Comparison

MetricIDXX (2025)DHR (2025)
Operating Cash Flow i1.17B5.64B
Operating Cash Flow % of Revenue i27.3%23.0%
Capital Expenditures i-124.68M-1.12B
Free Cash Flow i1.04B5.26B
FCF Margin i24.2%21.4%
Debt Repayment i-428.39M-500.00M
Common Stock Repurchase i-1.22B-3.09B

Short Interest & Institutional Ownership Analysis

MetricIDXXDHR
Shares Short i1.91M6.94M
Short Ratio i3.851.68
Short % of Float i2.74%1.10%
Shares Outstanding i79.71M707.70M
Float Shares i78.75M630.65M
% Held by Insiders i0.71%10.78%
% Held by Institutions i96.04%85.08%
% Held by Public i3.25%4.14%

Dividend Analysis & Yield Comparison: Idexx Laboratories, Inc. vs Danaher Corporation

MetricIDXXDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025